Crosslinked albumin hydrogels

Details Crosslinked albumin hydrogels Crosslinked albumin hydrogels

2006-06-06

2006-06-06

Weber, Ion (Department: 1654)

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

Albumin

C530S350000, C530S380000, C525S054100, C525S054110, C525S054200, C528S354000, C528S361000

Reexamination Certificate

active

07057019

ABSTRACT:
Materials, methods, and compositions for making crosslinked albumin hydrogels are included in the application. Embodiments include a biocompatible material of albumin crosslinked with an n-functional crosslinking agent wherein n is at least 3. Other embodiments include a cross-linking agent having a polyalkylene oxide member. Other embodiments include a system for administering an albumin material, the system having albumin and a crosslinking agent that reacts with the albumin to form a crosslinked material made of crosslinked albumin. Another embodiment is a method of making a biocompatible material that includes a step of mixing albumin with an n-functional crosslinking agent wherein n is at least 3.

REFERENCES:
patent: 2533004 (1950-12-01), Ferry et al.
patent: 3520949 (1970-07-01), Shepard et al.
patent: 4101380 (1978-07-01), Rubinstein et al.
patent: 4359049 (1982-11-01), Redl et al.
patent: 4565784 (1986-01-01), Franzblau et al.
patent: 4601286 (1986-07-01), Kaufman
patent: 4631055 (1986-12-01), Redl et al.
patent: 4646730 (1987-03-01), Schonfeld et al.
patent: 4735616 (1988-04-01), Eibl et al.
patent: 4874368 (1989-10-01), Miller et al.
patent: 4902281 (1990-02-01), Avoy
patent: 4932942 (1990-06-01), Maslanka
patent: 4937270 (1990-06-01), Hamilton et al.
patent: 4938763 (1990-07-01), Dunn
patent: 4978336 (1990-12-01), Capozzi et al.
patent: 5030215 (1991-07-01), Morse et al.
patent: 5041292 (1991-08-01), Feijen
patent: 5104909 (1992-04-01), Grasel
patent: 5116315 (1992-05-01), Capozzi et al.
patent: 5143662 (1992-09-01), Chesterfield et al.
patent: 5162430 (1992-11-01), Rhee et al.
patent: 5192743 (1993-03-01), Hsu et al.
patent: 5296518 (1994-03-01), Grasel
patent: 5304595 (1994-04-01), Rhee et al.
patent: 5318524 (1994-06-01), Morse et al.
patent: 5324775 (1994-06-01), Rhee et al.
patent: 5328955 (1994-07-01), Rhee et al.
patent: 5368563 (1994-11-01), Lonneman et al.
patent: 5395923 (1995-03-01), Bui-Khac et al.
patent: 5399351 (1995-03-01), Leshchiner et al.
patent: 5405607 (1995-04-01), Epstein
patent: 5410016 (1995-04-01), Hubbell et al.
patent: 5413791 (1995-05-01), Rhee et al.
patent: 5419491 (1995-05-01), Breitsprecher
patent: 5426148 (1995-06-01), Tucker
patent: 5446090 (1995-08-01), Harris
patent: 5446091 (1995-08-01), Rhee et al.
patent: 5455027 (1995-10-01), Zalipsky et al.
patent: 5470911 (1995-11-01), Rhee et al.
patent: 5474540 (1995-12-01), Miller et al.
patent: 5475052 (1995-12-01), Rhee et al.
patent: 5476909 (1995-12-01), Kim et al.
patent: 5505704 (1996-04-01), Pawelka et al.
patent: 5514379 (1996-05-01), Weissleder et al.
patent: 5514380 (1996-05-01), Song et al.
patent: 5527856 (1996-06-01), Rhee et al.
patent: 5529914 (1996-06-01), Hubbell et al.
patent: 5550187 (1996-08-01), Rhee et al.
patent: 5565519 (1996-10-01), Rhee et al.
patent: 5567435 (1996-10-01), Hubbell et al.
patent: 5573934 (1996-11-01), Hubbell et al.
patent: 5583114 (1996-12-01), Barrows
patent: 5605541 (1997-02-01), Holm
patent: 5614587 (1997-03-01), Rhee et al.
patent: 5626863 (1997-05-01), Hubbell et al.
patent: 5631322 (1997-05-01), Veronese et al.
patent: 5643464 (1997-07-01), Rhee et al.
patent: 5656035 (1997-08-01), Avoy
patent: 5672622 (1997-09-01), Hedgepeth et al.
patent: 5702361 (1997-12-01), Evans et al.
patent: 5741223 (1998-04-01), Janzen et al.
patent: 5744545 (1998-04-01), Rhee et al.
patent: 5749968 (1998-05-01), Melanson et al.
patent: 5752974 (1998-05-01), Rhee et al.
patent: 5773025 (1998-06-01), Baichwal
patent: 5786421 (1998-07-01), Rhee et al.
patent: 5800541 (1998-09-01), Rhee et al.
patent: 5807581 (1998-09-01), Rosenblatt et al.
patent: 5810885 (1998-09-01), Zinger
patent: 5844023 (1998-12-01), Tomka
patent: 5874500 (1999-02-01), Rhee et al.
patent: 5932462 (1999-08-01), Harris et al.
patent: 5936035 (1999-08-01), Rhee et al.
patent: 5951583 (1999-09-01), Jensen et al.
patent: 6051248 (2000-04-01), Sawhney et al.
patent: 6051648 (2000-04-01), Rhee et al.
patent: 6110484 (2000-08-01), Sierra
patent: 6124273 (2000-09-01), Drohan et al.
patent: 6153531 (2000-11-01), Bothra et al.
patent: 6162241 (2000-12-01), Coury et al.
patent: 6201065 (2001-03-01), Pathak et al.
patent: 6214966 (2001-04-01), Harris
patent: 6258351 (2001-07-01), Harris
patent: 6312725 (2001-11-01), Wallace et al.
patent: 6371975 (2002-04-01), Cruise et al.
patent: 6458889 (2002-10-01), Trollsas et al.
patent: 6465001 (2002-10-01), Hubbell et al.
patent: 2004/0076602 (2004-04-01), Harris
patent: WO 91/09641 (1991-07-01), None
patent: WO 94/03155 (1994-02-01), None
patent: WO 96/03159 (1996-02-01), None
patent: WO 97/22371 (1997-06-01), None
patent: WO 98/35631 (1998-08-01), None
patent: WO 99/10022 (1999-03-01), None
patent: WO 99/14259 (1999-03-01), None
patent: WO 99/22770 (1999-05-01), None
patent: WO 99/34833 (1999-07-01), None
US 6,214,374, 04/2001, Schmirler et al. (withdrawn)
Gayet et al., Journal of Controlled Release, vol. 38, pp. 177-184, 1996.
Molina et al., Biomaterials, vol. 22, pp. 363-369, 2001.
Kissel et al., Advanced Drug Delivery Reviews, vol. 54, pp. 99-134, 2002.
Wang et al., “Hydrogels as Separation Agents,”Advances in Polymer Science110:67-79 (1993).
Sierra, “Fibrin Sealant Adhsesive Systems: A Review of Their Chemistry, Material Properties and Clinical Applications,”Journal of Biomaterials Applications7:309-352 (1993).
Sierra, et al., “A Method to determine Shear Adhesive Strength of Fibrin Sealants,”Journal of Applied Biomaterials, 3:147-151 (1992).
Bick, “Physiology and Pathophysiology of Hemostasis During Cardiac Surgery” (excerpts).
Bick, “Hemostasis Defects,”Seminars in Thrombosis and Hemostasis11:263-264 (1985).
Vermes, “Cerebrospinal Fluid Proteins: I. Comparative Study of Concentration Methods,”Arq Neuropsiquiatr41:1-8 (1983) (abstract).
Kluge et al., “Results of Comparisons of Various Methods of Detennining Total Cerebrospinal Fluid Protein,”Dtsch Gesundheitsw23:2039-2041 (1968) (abstract).
Keller et al., “Determination of the Protein Concentration in the Cerebrospinal Fluid. Criticism of the Methods,”Med We/t23:1319-1325(1969) (abstract).
Burgi, “A Simple Method for the Concentration of Protein for Electrophoresis of Urine and Cerebrospinal Fluid,”Z Klin Chem Klin Biochem 5:277 (1967) (abstract).
Garrett et al., “Human Serum Albumin Adsorption of Hydrogel Contact Lenses In Vitro,”Invest aphtha/mol Vis Sci37:2594-2602 (1996) (abstract).
Kulik et al., “In Vitro Platelet Adhesion to Nonionic and Ionic Hydrogels with Different Water Contents,”J Biomed Mater Res30:295-304 (1996) (abstract).
Achterberg et al., “Hydroactive Dressings and Serum Proteins: An In Vitro Study,”J Wound Care 5:79-82 (1996)(abstract).
Saraydin et al., “Adsorption of Bovine Serum Albumin onto Acrylamide-Maleic Acid Hydrogels,”Biomateria/s15:917-920 (1994) (abstract).
Silver et al., “Effect of Protein Adsorption on the Blood-Contacting Response of Sulphonated Polyurethanes,”Biomateria/s14:834-844 (1993) (abstract).
Smith et al., “Thrombin and Albumin Adsorption to PV A and Heparin-PV A Hydrogels. 2: Competition and Displacement,”J Biomed Mater Res27:89-95 (1993) (abstract).
Smith et al., “Thrombin and Albumin Adsorption to PV A and Heparin-PV A Hydrogels. I Single Protein Isotherms,”J. Biomed Mater Res27:89-95 (1993) (abstract).
Lazarus et al., “Selective In Vivo Removal of Rheumatoid Factor by an Extracorporeal Treatment Device in Rheumatoid Arthritis Patients,”Transfusion31:122-128 (1991) (abstract).
Baines et al., “Adsorption and Removal of Protein Bound to Hydrogel Contact Lenses,”Optom Vis Sci67:807-810 (1990) (abstract).
Lin et al., “The Influence of Adsorption of Native and Modified Antibodies on Their Activity,”J Immunol Methods125:67-77 (1989) (abstract).
Bite et al., “Macrosorb Kieselguhr-Agarose Composite Adsorbents. New Tools for Downstream Process Design and Scale Up. Scientific Note,”App/ Biochem Biote

Affiliated with

Also associated with

Rating

Crosslinked albumin hydrogels does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Crosslinked albumin hydrogels, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crosslinked albumin hydrogels will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3655226